Login to Your Account

Delinia fits Celgene to a ‘T’ in potential $775M acquisition

By Marie Powers
News Editor

Thursday, January 26, 2017

Startup Delinia Inc. hitched its potentially transformative immune regulatory wagon to the Celgene Corp. train, agreeing to a potential $775 million acquisition.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription